Wirkmechanismus von Estriol

Kuiper GG, et al. (1996). Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U. S. A:;93(12):5925-5930.

Gruber C., et al. (2002). Production and actions of estrogens. The New England journal of medicine. 2002;346(5):340-352.

Bergink EW (1980). Oestriol receptor interactions: their biological importance and therapeutic implications. Acta endocrinologica. Supplementum;233:9-16.

Kuiper GG, et al. (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology;138(3):863-870.

Buquoy (Graf von), F., & Schröck, R. (1982). Lokaltherapie mit Estriol in der Gynäkologie (Ergebnisse einer klinisch-ambulanten Studie). Gyne 2 (Sonderdruck).

Haspels, A., Luisi, M., & Kicovic, P. (1981, Dec). Endocrinological and clinical investigations in post-menopausal women following administration of vaginal cream containing oestriol. Maturitas, 3(3-4), pp. 321-7.

Luisi, M., Franchi, F., & Kicovic, P. (1980, Dec). A group-comparative study of effects of Ovestin cream versus Premarin cream in post-menopausal women with vaginal atrophy. Maturitas, 2(4), pp. 311-9.

Henriksson, L., et al. (1994, Sep). A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol, 171(3), pp. 624-32.

Genazzani, A., Inaudi, F., La Rosa, R., & al., e. (1982). Oestriol and the menopause – Clinical and endocrinological results of vaginal administration. Serono Symposium No. 39. In P. Fioretti, L. Martini, G. Melis, & S. Yen (Eds.). London, New York: Academic Press.

Yoshimura, T., & Okamura, H. (2001, Sep). Short term oral estriol treatment restores normal premenopausal vaginal flora to elderly women. Maturitas, 39(3), pp. 253-7.

Kuhl H. (1998). Pharmakologie von Sexualsteroiden. Gynäkologe; 31:832-847.

L'Hermite M, et al. (1979). Unaltered basal prolactin secretion during short-term oestriol treatment in post-menopausal women. Clinical endocrinology;11(2):173-177.

Lindsay R, et al. (1979). Bone loss during oestriol therapy in postmenopausal women. Maturitas;1(4):279-285.

Michaelsson K, et al. (2002). Use of low potency estrogens does not reduce the risk of hip fracture. Bone;30(4):613-618.